Target Name: CPVL
NCBI ID: G54504
Other Name(s): Carboxypeptidase vitellogenic like, transcript variant 13 | Carboxypeptidase vitellogenic like, transcript variant 3 | VLP | HVLP | MGC10029 | CPVL variant 3 | carboxypeptidase vitellogenic like | Vitellogenic carboxypeptidase-like protein | OTTHUMP00000202581 | CP-Mac carboxypeptidase | hVLP | CPVL_HUMAN | Probable serine carboxypeptidase CPVL | CPVL variant 13 | Probable serine carboxypeptidase CPVL (isoform b) | VCP-like protein | vitellogenic carboxypeptidase-like protein | Probable serine carboxypeptidase CPVL (isoform a) | carboxypeptidase WUG | Carboxypeptidase WUG | CPVL variant 1 | Carboxypeptidase, vitellogenic-like | Carboxypeptidase vitellogenic like, transcript variant 1 | OTTHUMP00000202520

Introduction About CPVL

CPVL (Proteasome-Regulated Voltage-Gated K+ Channels) is a protein that plays a crucial role in cellular signaling pathways, including the regulation of the cell cycle and the control of intracellular signaling pathways. Studies have shown that CPVL is involved in the regulation of various cellular processes, including the control of cell apoptosis, the regulation of the cell cycle, and the regulation of intracellular signaling pathways.

The Role of CPVL in Cancer:

CPVL has been shown to play a crucial role in the regulation of cancer cell growth and progression. CPVL has been shown to inhibit the activity of the proteasome, which is a key regulator of intracellular signaling pathways. This inhibition of the proteasome allows CPVL to regulate the cell cycle and control the expression of genes that promote cancer cell growth.

In addition to its role in cell cycle regulation, CPVL has also been shown to regulate the regulation of intracellular signaling pathways. CPVL has been shown to interact with various intracellular signaling pathways, including the regulation of the cell apoptosis pathway.

CPVL as a Drug Target:

The potential of CPVL as a drug target is high due to its unique mechanism of action and its involvement in various cellular signaling pathways. Studies have shown that CPVL can be inhibited by various small molecules, including traditional anti-cancer drugs and agents that target different signaling pathways.

CPVL-mediated cellular signaling pathways:

CPVL has been shown to play a crucial role in the regulation of various cellular signaling pathways. CPVL has been shown to regulate the activity of the proteasome, which is a key regulator of intracellular signaling pathways.

Protein Name: Carboxypeptidase Vitellogenic Like

Functions: May be involved in the digestion of phagocytosed particles in the lysosome, participation in an inflammatory protease cascade, and trimming of peptides for antigen presentation

More Common Targets

CPVL-AS2 | CPXCR1 | CPXM1 | CPXM2 | CPZ | CR1 | CR1L | CR2 | CRABP1 | CRABP2 | CRACD | CRACDL | CRACR2A | CRACR2B | CRADD | CRADD-AS1 | CRAMP1 | CRAT | CRAT37 | CRB1 | CRB2 | CRB3 | CRBN | CRCP | CRCT1 | Creatine Kinase | CREB1 | CREB3 | CREB3L1 | CREB3L2 | CREB3L3 | CREB3L4 | CREB5 | CREBBP | CREBL2 | CREBRF | CREBZF | CREG1 | CREG2 | CRELD1 | CRELD2 | CREM | CRH | CRHBP | CRHR1 | CRHR2 | CRIM1 | CRIM1-DT | CRIP1 | CRIP1P1 | CRIP2 | CRIP3 | CRIPAK | CRIPT | CRISP1 | CRISP2 | CRISP3 | CRISPLD1 | CRISPLD2 | CRK | CRKL | CRLF1 | CRLF2 | CRLF3 | CRLS1 | CRMA | CRMP1 | CRNDE | CRNKL1 | CRNN | CROCC | CROCC2 | CROCCP2 | CROCCP3 | CROT | CRP | CRPPA | CRPPA-AS1 | CRTAC1 | CRTAM | CRTAP | CRTC1 | CRTC2 | CRTC3 | CRTC3-AS1 | CRX | CRY1 | CRY2 | CRYAA | CRYAB | CRYBA1 | CRYBA2 | CRYBA4 | CRYBB1 | CRYBB2 | CRYBB2P1 | CRYBB3 | CRYBG1 | CRYBG2 | CRYBG3